Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study suggests immune-based cancer therapies might be particularly beneficial for HIV-positive people.
HIV-positive people who underwent surgery to remove early lung cancer fared as well as HIV-negative people.
They also have a higher rate of death from cancer after receiving a diagnosis.
Keytruda and Imfinzi were well tolerated and responses were similar to those seen in HIV-negative people.
The disease tends to strike HIV-positive individuals at younger ages and with less smoking experience than the general population.
That’s compared with using patches, gum, lozenges, sprays, inhalers or a combination of such products.
One hundred twenty volunteers to enroll in Seattle-area study of cancer-related gene mutations
Hopefully, continued advances will make cancer as treatable as HIV -- or as curable as hepatitis C.
The cancer rate of those living with HIV in the U.S. is expected to decline in the next decade.
Smokers in particular would reduce their risk of death similarly through such screening.
An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.
Declining rates are expected for Kaposi sarcoma, non–Hodgkin lymphoma, cervical and lung cancer and Hodgkin lymphoma, among others.
This is according to a meta-analysis of a dozen studies conducted in North America and Europe.
Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.
Researchers strongly advise those living with the virus to quit cigarettes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.